[Specific suppression of arthritis rheumatoid by Fas/Fas ligand].
Sumida
T
T
Hasunuma
T
T
Asahara
H
H
Maeda
T
T
Nishioka
K
K
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D017209:Apoptosis; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy; D004195:Disease Models, Animal; D053222:Fas Ligand Protein; D006801:Humans; D008562:Membrane Glycoproteins / Q000276:immunology; D011948:Receptors, Antigen, T-Cell; D019014:fas Receptor / Q000276:immunology
D000911:Antibodies, Monoclonal; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D011948:Receptors, Antigen, T-Cell; D019014:fas Receptor